The microscope-in-a-needle was developed in the Optical + Biomedical Engineering Laboratory (OBEL) at The University of Western Australia (UWA) to assist surgeons with identifying which tissue to remove during surgery minimising the risk of missing cancer cells. Originally developed for breast cancer surgery the device has the potential for applications that include brain and lung cancer biopsy as well as an assessment tool for new drugs.
In 2014 UWA entered the WA innovator of the Year program and was selected as a Winner in the Emerging Innovation category. Microscope-in-a-needle also received industry recognition when they were awarded Winner of the 2014 SPIE Startup Challenge. SPIE is the international society for optics and photonics.
Accelerating Commercialisation provided UWA assistance in the form of a grant and an advisor, which helped with taking the microscope-in-a-needle to market.
The team at OBEL are leveraging the technology developed in microscope-in-a-needle to develop a nanoscope-in-a-needle. The nanoscope-in-a-needle project is funded by an Australian Research Council grant.
A new Australian start-up company is currently finalising licensing of key patents from UWA.
Help along the way
- UWA – OBEL Optical + Biomedical Engineering Laboratory
- Accelerating Commercialisation
- Innovator of the Year
- 2012 Eureka Prize for Innovative Use of Technology finalist
- 2013 Eureka Prize for Innovative Use of Technology finalist
- 2014 Innovator of the Year Emerging Innovation category winner
- 2014 SPIE Startup Challenge winner
- 2015 The Australian Innovation Challenge
In the media
- World accolades for EECE Winthrop Professor and CMCA Director David Sampson for the microscope-in-a-needle
- Accelerating Commercialisation customer stories - Fighting breast cancer with a miniature imaging device
- UWA's microscope-in-a-needle wins prestigious national award
- Microscope in a needle an award finalist